Skip to NavigationSkip to content

Pharmafile - Sales and Marketing News

Ex-Valeant CEO Michael Pearson is suing his former company over its failure to deliver three million shares he claims he is owed as part of his...
The EMA’s Committee for Medicinal Products for Human Use (CHMP) has called for the suspension of 331 drugs due to concerns over “misrepresentation...
Following on from the positive opinion given to Xeljanz in January of this year, Pfizer’s drug has now been given European Commission marketing...
Infectex, a Russian portfolio company of Maxwell Biotech Venture Fund, announced that it had found positive results from its latest Phase 2b-3...
AstraZeneca has been boosted by the news that its drug, Tagrisso, has become its first drug to be approved under China’s new Priority Review pathway.
Merck KGaA and Pfizer have won approval for the fourth immunotherapy treatment to enter the market, with an indication in metastatic Merkel cell...
Eli Lilly’s latest press release indicated that it would be spending $850 million in developing its worldwide US operations, particularly in its...
As Novartis' once-promising heart failure drug plummets in Phase 3 trials and the FDA approves the first Parkinson's treatment in a decade, check out...
According to reports emerging, Sanofi may be on the verge of closing a deal with Burlington-based biotech, Flexion Therapeutics. The deal is thought...